课题基金 / 基金详情

CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES

CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES
活化人类白细胞的临床试验
批准号：
3614787
负责人：
JAMES H DOROSHOW
金额：
$72.4万
依托单位：
CITY OF HOPE NATIONAL MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1987
资助国家：
美国
项目状态：
已结题
起止时间：
1987-06-30 至 1991-06-29
来源：
https://reporter.nih.gov/project-details/3614787
关键词：
combination cancer therapy drug adverse effect human subject human therapy evaluation leukocyte activation /transformation longitudinal human study neoplasm /cancer immunotherapy terminal patient care

项目摘要

项目成果

JAMES H DOROSHOW的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Contractor shall perform clinical evaluations of treatment regimens utilizing activated leukocytes sponsored by the Division of Cancer Treatment, NCI, under an investigational new drug application (IND). Specifically, the Contractor shall: 1) determine the antitumor activity of activating agents in combination with activated leukocytes in a variety of human cancers in patients with advanced disease and minimal prior therapy; 2) define the toxicities of activating agents administered in combination with activated leukocytes to patients with advanced cancer; 3) evaluate new methods for activation of leukocytes and determine the antitumor activity of activated leukocytes generated using the new methodology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Phase I Pharmacokinetic Study of STI-571 in Patients
A Phase I Pharmacokinetic Study of STI-571 in Patients
PHI-39: Phase I Trial of #7389 (Halichondrin B Analog)
  • 批准号：
    7040129
  • 项目类别：
  • 资助金额：
    $16.26万
  • 财政年份：
    2003
  • 负责人：
    JAMES H DOROSHOW
  • 依托单位：
    UNIVERSITY OF SOUTHERN CALIFORNIA
MDR1 GENE THERAPY IN CD34+ CELLS AND SCID MICE